Role of bupivacaine in hernia surgery for post operative pain

The analgesic effect and patient satisfaction following bupivacaine infiltration in the extra peritoneal space in patients undergoing laparocopic TAPP repair for unilateral inguinal hernias A Randomized controlled Trial - NIL

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/073692

Enrollment

202

Registered

2024-09-10

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K409- Unilateral inguinal hernia, without obstruction or gangrene

Interventions

Intervention1: Bupivacaine: Bupivacaine 0.5% , with 2mg/kg dosage through port sites will be infiltrated in extraperitoneal TAPP space after mesh placement and drug will be absorbed from flap and pos

Eligibility

Inclusion criteria

Inclusion criteria: All male patients between specified age undergoing unilateral TAPP will be included

Exclusion criteria

Exclusion criteria: Recuurent hernia , Previous laparotomy ,substance abuse or opium addiction , psychiatric patients, uncontrolled comorbidities, history of drug allergy

Design outcomes

Primary

Measure	Time frame
Analgesic effect of bupivacine infiltration into port wounds and extraperitoneal space compared to placebo (normal saline) after 6 ,12 , 24 hours of surgeryTimepoint: VAS pain score after 6 ,12 , 24 hours of surgery	—

Secondary

Measure	Time frame
To compare patient satisfaction levelTimepoint: At time of discharge from the hospital ( 1 or 2 days after OT )	—

Countries

India

Contacts

Public ContactDr Satya Prakash Meena

AIIMS Jodhpur

drsatyaprakash04@gmail.com8010861072

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026